An interventional study of During laparoscopic fundoplication, one group secures the esophagus to the diaphragm. in Gastroesophageal Reflux Disease, sponsored by Nanchong Central Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by Nanchong Central Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Gastroesophageal Reflux with a site in China — 16 open to participants now, 17 under way, none of them phase 3. Gastroesophageal Reflux · China.
Among the 56 studies in Gastroesophageal Reflux with a site in China, this one is the 5th largest by planned enrollment of the 39 interventional ones that give a count, is one of 5 that started in 2025, is one of 24 with no phase, reaches primary completion later than 9 of the 16 other live ones, and was the 55th registered.
1,215 studies on the registry are indexed under Gastroesophageal Reflux; 203 are open to participants now.
Browse Gastroesophageal Reflux studies →16 of the 56 studies in Gastroesophageal Reflux with a site in China are open now. Recruiting first, the newest first:
Xinghua Liu · Sites in China
Ages 18–65
Beijing Friendship Hospital · Sites in China
Ages 18–90
Second Affiliated Hospital, School of Medicine, Zhejiang University · Sites in China
Ages 18+
Shanghai Hutchison Pharmaceuticals Limited · Sites in China
Ages 18–75
Beijing Friendship Hospital · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 133 Gastroesophageal Reflux studies recruiting now, 57 (43%) set no upper age limit and 53 (40%) stop at 75 or younger; 22 take children under 18; 20 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 4 · Phase 3 7 · Phase 4 2
First in 2003; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 240 is above the median of 68 across 799 interventional studies indexed under Gastroesophageal Reflux.
Median enrollment 90 across the 39 interventional studies, 1,625 across the 17 observational. Of the 24 that completed or were terminated, 5 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 56 have an industry lead sponsor. The 10 most frequent:
Nanchong Central Hospital is the lead sponsor of 21 studies on the registry; 14 are open to participants now.
Nanchong Central Hospital has 2 studies filed under Gastroesophageal Reflux — fewer than ten, so there is no comparison to draw.
5 of the studies in Gastroesophageal Reflux with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07749989Beijing Friendship HospitalA Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset | 2027-04 |
| NCT07943611Nanchong Central HospitalLaparoscopic Fundoplication With or Without Fixation to the Diaphragm for Gastroesophageal Reflux Disease or Hiatal Hernia | 2027-06-30 |
| NCT06755671Shanghai Hutchison Pharmaceuticals LimitedA Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms | 2027-06-30 |
| NCT07795645Beijing Friendship HospitalValidating a Medical AI Fine-Tuning Platform for Major Diseases | 2027-08-31 |
| NCT07854613China-Japan Friendship HospitalDe Novo Gastroesophageal Reflux Disease After Sleeve Gastrectomy With and Without Omentopexy | 2027-10-15 |
Add all 5 to your calendar (.ics) → With an account.
Among the 56 studies in Gastroesophageal Reflux with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To compare the clinical efficacy of fixation to diaphragm or not during fundoplication in patients with GERD, and to provide high-level evidence for clinical surgical decision-making.
Enrolled patients were were randomly divided into two groups, one fixed to the diaphragm or the other not fixed to the diaphragm during laparoscopic fundoplication.
The primary outcome was recurrence of GERD, assessed by endoscopy and/or 24-hour pH monitoring at 6 and 12 months after surgery. Reoperation for recurrent GERD or hiatal hernia was also recorded.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: During laparoscopic fundoplication, one group secures the esophagus to the diaphragm.
During laparoscopic fundoplication, one group secures the esophagus to the diaphragm.
The primary outcome was recurrence of GERD, assessed by endoscopy and/or 24-hour pH monitoring, and reoperation for recurrent GERD or hiatal hernia was also recorded.
Time frame: At12 months after surgery
Secondary outcomes included postoperative complications, including reflux symptoms, abdominal pain, indigestion, and dysphagia, GERD-HRQL assessed symptom severity and QoL improvement pre-treatment vs. post-treatment at 6 and 12 months post-surgery.
Time frame: At 12 months after surgery
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2025 (actual). Primary completion is estimated for Jun 2027, 29 months after the start.
Of 193 non-industry interventional studies with no phase under Gastroesophageal Reflux, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 68. This study's planned 29 months is close to that.
Counting every sponsor, half of 227 studies reached it within 31 months; a quarter within 12 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nanchong Central Hospital